BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 36397354)

  • 1. L-carbocisteine can cause cholestasis with vanishing bile duct syndrome in children: A case report.
    Takaki Y; Murahashi M; Honda K; Hirai K
    Medicine (Baltimore); 2022 Nov; 101(45):e31486. PubMed ID: 36397354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meropenem-induced vanishing bile duct syndrome.
    Schumaker AL; Okulicz JF
    Pharmacotherapy; 2010 Sep; 30(9):953. PubMed ID: 20812433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vanishing Bile Duct Syndrome Secondary to Hodgkin Lymphoma in a Child.
    Palla Velangini S; Boddu D; Balakumar S; Premanand A; Kishore R; Mathew LG
    J Pediatr Hematol Oncol; 2022 Aug; 44(6):e945-e947. PubMed ID: 35796591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meropenem-induced vanishing bile duct syndrome: A case report.
    Zubarev A; Haji K; Li M; Tiruvoipati R; Botha J
    J Int Med Res; 2020 Aug; 48(8):300060520937842. PubMed ID: 32865076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinicopathologic features of drug-induced vanishing bile duct syndrome].
    Ye LH; Wang CK; Zhang HC; Liu ZQ; Zheng HW
    Zhonghua Gan Zang Bing Za Zhi; 2017 Apr; 25(4):317-320. PubMed ID: 28494557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vanishing bile duct syndrome in Hodgkin's lymphoma: A case report and literature review.
    Bakhit M; McCarty TR; Park S; Njei B; Cho M; Karagozian R; Liapakis A
    World J Gastroenterol; 2017 Jan; 23(2):366-372. PubMed ID: 28127210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vanishing bile duct syndrome related to DILI and Hodgkin lymphoma overlap: A rare and severe case.
    Greca RD; Cunha-Silva M; Costa LBE; Costa JGF; Mazo DFC; Sevá-Pereira T; Nascimento MMC; Pereira IE; Oliveira FC; Faria GAS; Neto FLP; Almeida JRS
    Ann Hepatol; 2020; 19(1):107-112. PubMed ID: 31537508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two-dimensional ultrasonography and CEUS of a case with primary biliary cholangitis and vanishing bile duct syndrome.
    Yu P; Zhou Y; Li X
    J Clin Ultrasound; 2022 Nov; 50(9):1368-1372. PubMed ID: 36149806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vanishing bile duct syndrome as a manifestation of Hodgkin's lymphoma: a case report and review of the literature.
    Nader K; Mok S; Kalra A; Harb A; Schwarting R; Ferber A
    Tumori; 2013; 99(4):e164-8. PubMed ID: 24326854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ursodeoxycholic acid treatment of vanishing bile duct syndromes.
    Pusl T; Beuers U
    World J Gastroenterol; 2006 Jun; 12(22):3487-95. PubMed ID: 16773706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vanishing bile duct syndrome in a Hodgkin's lymphoma patient with fatal outcome despite lymphoma remission.
    Aleem A; Al-Katari M; Alsaleh K; AlSwat K; Al-Sheikh A
    Saudi J Gastroenterol; 2013; 19(6):286-9. PubMed ID: 24195983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vanishing bile duct syndrome and immunodeficiency preceding the diagnosis of Hodgkin lymphoma.
    Yeh P; Lokan J; Anantharajah A; Grigg A
    Intern Med J; 2014 Dec; 44(12a):1240-4. PubMed ID: 25442758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vanishing bile duct syndrome with hyperlipidemia after ibuprofen therapy in an adult patient: a case report.
    Xie W; Wang Q; Gao Y; Pan CQ
    BMC Gastroenterol; 2018 Sep; 18(1):142. PubMed ID: 30268094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vanishing Bile Duct Syndrome in the Presence of Hodgkin Lymphoma.
    Gaudel P; Brown P; Byrd K
    Cureus; 2022 Jul; 14(7):e26842. PubMed ID: 35974868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful Treatment with Steroids in a Patient with Vanishing Bile Duct Syndrome and Acute Tubular Necrosis.
    Mizuno F; Imai N; Yasuda K; Yokoyama S; Yamamoto K; Ito T; Ishizu Y; Honda T; Ishigami M; Kawashima H
    Intern Med; 2024 Jan; 63(1):57-61. PubMed ID: 37164665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atypical primary biliary cholangitis results in vanishing bile duct syndrome with cutaneous xanthomas: a case report.
    Jia Y; Liu L; Deng B; Huang Y; Zhao J; Bai G
    Diagn Pathol; 2022 Jul; 17(1):57. PubMed ID: 35787279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Case of Vanishing Bile Duct Syndrome after Drug-Induced Liver Injury Caused by Pelubiprofen.
    Bak H; Kim H; Lee S; Lee Y; Bang SM; Lee YS
    Yonsei Med J; 2020 Dec; 61(12):1060-1063. PubMed ID: 33251781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sertraline-Associated Cholestasis and Ductopenia Consistent with Vanishing Bile Duct Syndrome.
    Conrad MA; Cui J; Lin HC
    J Pediatr; 2016 Feb; 169():313-5.e1. PubMed ID: 26597434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cloxacillin-induced acute vanishing bile duct syndrome: A case study and literature review.
    Faragalla K; Lau H; Wang HL; Liu J
    Br J Clin Pharmacol; 2022 Oct; 88(10):4633-4638. PubMed ID: 35730139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infliximab-Induced Vanishing Bile Duct Syndrome.
    Eiswerth MJ; Heckroth MA; Ismail A; Gondim DD; Kaufman R
    Cureus; 2022 Feb; 14(2):e21940. PubMed ID: 35273881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.